At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
F18 NaF PET/CT and Whole Body and Axial MRI for the Detection of Metastases in Patients With Biochemical Recurrence of Prostate Cancer
In Brief
A clinical study evaluating computed tomography, bone scan, and 5 other interventions for Recurrent Prostate Cancer. Completed, enrolled 54 participants across 2 sites.
Detailed Summary
This phase II trial studies how well fluorine F 18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) and whole body and axial magnetic resonance imaging (MRI) work in finding metastases in patients with recurrent prostate cancer. New imaging techniques, such as fluorine F 18 sodium fluoride PET/CT and whole body and axial MRI, may be more effective than standard CT and bone scan in finding metastatic prostate cancer.
Study Details
Timeline
Interventions
Undergo CT
Undergo bone scan
Undergo axial MRI
Undergo WB MRI
Undergo fluorine F 18 sodium fluoride PET/CT
Undergo fluorine F 18 sodium fluoride PET/CT
Undergo fluorine F 18 sodium fluoride PET/CT
Correlative studies